vcfirmsdirectory.com

Venture capital · Early stage · Est. 1979

Sanderling Ventures

Sanderling Ventures is a specialist venture firm that builds new biomedical companies, working closely with entrepreneurs and staying involved over the long term.

San Mateo · MontrealRegistered · San Mateo
New investments · 12 months
Fund vehiclesPublic
8
8 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: sanderling.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Sanderling Ventures joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Sanderling Ventures right for your round?

Is Sanderling Ventures a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
8
8 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

SANDERLING VENTURES VII, L.P.US private fund · Active · United States · $98.7M gross assets · filed 31 Mar 2026
SANDERLING VENTURES PARTNERS VI CO-INVESTMENT FUND, L.P.US private fund · Active · United States · $26.6M gross assets · filed 31 Mar 2026
SANDERLING VENTURES VII (CANADA), L.P.US private fund · Active · Canada · $24.8M gross assets · filed 31 Mar 2026
SANDERLING VENTURES VII ANNEX FUND, LPUS private fund · Active · United States · $5.2M gross assets · filed 31 Mar 2026
SANDERLING V STRATEGIC EXIT FUND, L.P.US private fund · Active · United States · $3.1M gross assets · filed 31 Mar 2026
SANDERLING VENTURE PARTNERS VI, L.P.US private fund · Active · United States · $2.6M gross assets · filed 31 Mar 2026
SANDERLING VI LIMITED PARTNERSHIPUS private fund · Active · Cayman Islands · $92.9K gross assets · filed 31 Mar 2026
SANDERLING VI BETEILIGUNGS GMBH & CO. KGUS private fund · Active · Germany · $27.3K gross assets · filed 31 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

Rounds Sanderling Ventures joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round Sanderling Ventures joined

Round sizes, Sanderling Ventures’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

ActimisAderisAdvanced CardiovascularAltor BioScienceArtielleAsteresBioSpaceCalciMedicaCardioNetChimerixand 33 more

Portfolio and exits

Every company Sanderling Ventures backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Sanderling Ventures puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Sanderling Ventures

Events where Sanderling Ventures’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Sanderling Ventures’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

31 Mar 2026Fund filingForm ADV filed by SANDERLING MANAGEMENT COMPANY, LLC: 8 private funds, $161.1M in gross assets.SEC Form ADV · public record
16 Apr 2025New deal

Founders also look at

Frequently asked questions

Sanderling Ventures is based in San Mateo, United States. It also has an office in Montreal.

In 1979.

8 fund vehicles are on public registers (SEC adviser filings), including SANDERLING VENTURES VII, L.P., SANDERLING VENTURES PARTNERS VI CO-INVESTMENT FUND, L.P. and SANDERLING VENTURES VII (CANADA), L.P.

Stages: Early stage. Sectors: Biotech, Medtech. From the firm’s own website.

Sanderling holds that significant biomedical companies come from close partnerships with entrepreneurs. It pairs a narrow investment focus with hands-on management and a long-term commitment, aiming for strong returns for founders and investors alike. From the firm’s own website.

Sanderling Ventures lists 43 portfolio companies on its website, including Actimis, Aderis, Advanced Cardiovascular, Altor BioScience and Artielle.

Firms whose websites list some of the same companies include Alta Partners, 3VC and Advent Life Sciences.

Know before Sanderling Ventures’s next round is announced.

PRO tracks Sanderling Ventures’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Sanderling VenturesGet Sanderling Ventures’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.